Survival analysis, ADM2, IKBKE, IKBKE, IL11, IL15RA, PLXNA1, S100A16, TMSB10, and TOR2A were associated with poor prognosis in HCC patients (Fig. 4D). This evidence concerns the gene IL11 and hepatocellular carcinoma.